 Tel:+86-755-26890807
News Detail
Home / News / Company News / Goldsite COVID-19 SARS-Cov-2 Antigen Kit Passed UK DHSC Phase 3 Evaluation

Goldsite COVID-19 SARS-Cov-2 Antigen Kit Passed UK DHSC Phase 3 Evaluation

Author:Site Editor     Publish Time: 2021-07-08      Origin:Site

Goldsite COVID-19 SARS-Cov-2 Antigen Kit (Colloidal Gold) Passed the 3 Phase evaluation of rapid diagnostic assays for specific SARS-CoV-2 antigens (lateral flow devices) in United Kingdom of Department of Health & Social Care (UK DHSC) for its excellent performance, another groundbreaking moment marks it's recognized by global regulatory community, with excellent quality, as always.

registration date in the U.K. DHSC


Previously, Goldsite's new coronavirus series products have been approved by CE of EU, PEI of Germany, ANSM of France, BfArM of Germany, MHRA of UK, Ministry of Health of Italy, Ministry of Health of Spain and Romania.

Goldsite Diagnostics Inc., founded in 1999, is a leading Chinese diagnostics manufacturer specializing in in-vitro diagnostics devices and reagents.

Quick Links

Product Links

Get in touch

    (+86)-755-26890807

        (+86)-755-26897973
   frederic.fang@goldsite.com.cn(Division 1) 

       export@goldsite.com.cn(Division 2)

       service@goldsite.com.cn(Division 3)

       rina.qi@goldsite.com.cn(Division 4)

Copyright ©  2021 Goldsite Diagnostics Inc., All rights reserved.  Sitemap